Wei Gong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wei Gong has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Cong-Ting Wu
Institute of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China
2 shared publications- Jing Li
Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441021, China
2 shared publications Yu Pei
Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China
2 shared publicationsFen Hu
Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China
1 shared publicationHan-Xue Yang
Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China
1 shared publicationJia-Li Sun
Institute of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China
1 shared publication
Latest Publications
- Open Access
- 12 March 2026
- Published by Springer Nature in BMC Medicine
- Vol. 24 (1)
Downregulated lysyl oxidase in plasma extracellular vesicles: a biomarker linked to brain metastasis risk in lung adenocarcinoma
Brain metastasis (BrM) is a leading cause of mortality in patients with lung adenocarcinoma (LUAD). Extracellular vesicles (EVs), which carry bioactive mol
- 12 March 2026
- Published by Springer Nature in BMC Medicine
- Vol. 24 (1)
Open AccessDownregulated lysyl oxidase in plasma extracellular vesicles: a biomarker linked to brain metastasis risk in lung adenocarcinoma
Brain metastasis (BrM) is a leading cause of mortality in patients with lung adenocarcinoma (LUAD). Extracellular vesicles (EVs), which carry bioactive mol
- Open Access
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 27, 2460-2472
Applications of machine learning-assisted extracellular vesicles analysis technology in tumor diagnosis
Precision medicine for tumors represents a pivotal focus in contemporary medical research. Nonetheless, the diversity of tumor types and the complexity of their pathogenesis present significant challenges in the diagnostic process. Extracellular vesicles (EVs), as a category of nanoparticles, carry a wealth of biological information and play a crucial role in tumor initiation and progression, thereby offering novel approaches for early tumor diagnosis. In recent years, machine learning (ML) technology in the medical field has gained momentum, which utilize various algorithms to analyze input data, identify potential patterns and trends, develop predictive models, and generate high-precision predictions of unknown data, demonstrating its clinical potential in disease diagnosis. This review provides a comprehensive summary of advancements in EVs analysis technology based on ML for auxiliary tumor diagnosis, including early diagnosis, classification, stage recognition, and molecular diagnosis, and discusses their advantages in clinical applications. Additionally, the article anticipates future development trends in the field, aiming to serve as a reference for researchers engaged in ML-assisted liquid biopsy for tumor diagnosis.
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 27, 2460-2472
Open AccessApplications of machine learning-assisted extracellular vesicles analysis technology in tumor diagnosis
Precision medicine for tumors represents a pivotal focus in contemporary medical research. Nonetheless, the diversity of tumor types and the complexity of their pathogenesis present significant challenges in the diagnostic process. Extracellular vesicles (EVs), as a category of nanoparticles, carry a wealth of biological information and play a crucial role in tumor initiation and progression, thereby offering novel approaches for early tumor diagnosis. In recent years, machine learning (ML) technology in the medical field has gained momentum, which utilize various algorithms to analyze input data, identify potential patterns and trends, develop predictive models, and generate high-precision predictions of unknown data, demonstrating its clinical potential in disease diagnosis. This review provides a comprehensive summary of advancements in EVs analysis technology based on ML for auxiliary tumor diagnosis, including early diagnosis, classification, stage recognition, and molecular diagnosis, and discusses their advantages in clinical applications. Additionally, the article anticipates future development trends in the field, aiming to serve as a reference for researchers engaged in ML-assisted liquid biopsy for tumor diagnosis.